University of North Carolina at Chapel Hill logo

University of North Carolina at Chapel Hill

North America, North Carolina, United States, Chapel Hill

Description

University of North Carolina at Chapel Hill is the nation’s first public university.

Investor Profile

University of North Carolina at Chapel Hill has made 4 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series A (25%)
  • Grant (25%)

Country Focus

  • United States (75%)

Industry Focus

  • Software
  • Biotechnology
  • Medical
  • Medical Device
  • Neuroscience
  • Telecommunications
  • Video
  • Video On Demand
  • Cosmetics
  • Personal Care And Hygiene
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University of North Carolina at Chapel Hill frequently co-invest with?

Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Frazier Technology Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
DC
North America, Wisconsin, United States, Pewaukee
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
TIAA
North America, New York, United States, New York
Co-Investments: 2
Fluke Venture Partners
North America, Washington, United States, Kirkland
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3
PP
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by University of North Carolina at Chapel Hill?

Software for the Regulatory Cosmetics Industry. Global regulations and formula management.

CosmeticsPersonal Care and HygieneSaaSSoftware
GrantOct 26, 2024
Amount Raised: $2,500
NeurogesX

San Carlos, California, United States

NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.

BiotechnologyMedicalMedical DeviceNeuroscience
Series CFeb 24, 2004
Amount Raised: $35,000,000
Midstream Technologies

Bellevue, Washington, United States

Develops video on demand (VoD) and network digital video recording (nDVR) servers and solutions.

SoftwareTelecommunicationsVideoVideo on Demand
Series CAug 18, 2002
Amount Raised: $26,000,000
NeurogesX

San Carlos, California, United States

NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.

BiotechnologyMedicalMedical DeviceNeuroscience
Series AJun 1, 2000
Amount Raised: $8,400,000